Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fiberchoice

This article was originally published in The Tan Sheet

Executive Summary

Direct response TV ad supporting launch of CNS' chewable fiber supplement broke June 26; a dedicated Web site (www.fiberchoice.com) debuted the following day. The product, from the Minneapolis-based maker of Breathe Right nasal strips, is backed by a $17 mil. consumer and professional ad campaign (1"The Tan Sheet" April 3, p. 11). A 30-second spot also hit airwaves in mid-June on major networks, including CBS, ABC, CNN and Fox News; the ads target women over 50. Other marketing support includes direct mail to bulk fiber users and full-page ads in women's and health magazines

You may also be interested in...



FiberChoice $8 Mil. TV Campaign To Break In June

CNS, Inc. is supporting the launch of its FiberChoice chewable fiber supplement with a $17 mil. consumer and professional marketing campaign.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091373

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel